Biotech Bulls & Breakthroughs

https://is1-ssl.mzstatic.com/image/thumb/Podcasts221/v4/c1/a3/d0/c1a3d069-438c-2a3a-caee-ceb8facb7ee2/mza_13618382354171959920.jpg/600x600bb.jpg

BioPharmCatalyst

10 episodes

1 week ago

In this episode, John Gagliano and Sheff Sheffield discuss the current state of the biotech market as they approach the end of the year. They reflect on recent trading successes and challenges, emphasizing the importance of understanding catalysts and market reactions. The conversation also highlights the significance of insider trading and institutional movements in stock performance. Finally, they explore upcoming catalysts and provide insights into their stock watchlist for the remainder o...

All content for Biotech Bulls & Breakthroughs is the property of BioPharmCatalyst and is served directly from their servers with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.

Episodes (10/10)

Biotech Bulls & Breakthroughs

Understanding Catalysts in Biotech Trading

1 week ago

50 minutes

Biotech Bulls & Breakthroughs

Innovations in Biotech: A Deep Dive with MoMA Therapeutics

In this episode, John Gagliano speaks with Neil Lineberry, VP of Corporate Development at MoMA Therapeutics, about the innovative approaches the company is taking in drug development, with a particular focus on dynamic proteins and precision medicine. Neil shares his journey in biotech, the mission of MoMA Therapeutics, and insights into the current biotech market trends. The conversation also covers the company's pipeline, collaborations, and the Nomatic platform, highlighting the importance...

1 month ago

30 minutes

Biotech Bulls & Breakthroughs

Ep. 5: Biotech Trends and Insights: Rare Diseases, Patent Expirations, ESMO25 and Sheff's Watchlist | Biotech Bulls & Breakthroughs Podcast

In this episode of Biotech Bulls and Breakthroughs, John Gagliano and Christopher Sheffield discuss the current state of the biotech market, focusing on trends, upcoming catalysts, and the implications of patent expirations. They delve into the evolving landscape of rare diseases, the impact of Keytruda's patent expiration on Merck and the market, and highlight key upcoming events such as ESMO. The conversation also explores options trading in biotech and concludes with insights into future m...

1 month ago

51 minutes

Biotech Bulls & Breakthroughs

Ep. 4: Navigating the Biotech Landscape | Biotech Bulls & Breakthroughs Podcast

In this episode, John Gagliano and Sheff discuss the latest trends in the biotech market, focusing on key companies, earnings season insights, and upcoming catalysts. They highlight the importance of FDA communications and breakthrough designations, as well as the impact of recent data releases on stock performance. The conversation also touches on charity work and includes a brief interview with Billy Henry, the Founder of an organization that helps the visually impaired. In this episode: 🔹...

2 months ago

1 hour 5 minutes

Biotech Bulls & Breakthroughs

Biopharma Industry: Insights from BioSpace Senior Editor Annalee Armstrong

In this episode of Biotech Bulls and Breakthroughs, host John Gagliano speaks with Annalee Armstrong, Senior Editor at BioSpace, about the current state of the biopharma industry. They discuss exciting developments in neurodegenerative diseases, the hype surrounding GLP-1 drugs, the future of oncology, the psychedelic drug market, the role of the FDA, and the impact of AI on drug discovery. Annalee emphasizes the need for certainty in the biotech industry and the importance of focusing on goo...

3 months ago

30 minutes

Biotech Bulls & Breakthroughs

Ep. 3: Stock Picking and Catalyst Research | Biotech Bulls & Breakthroughs Podcast

In this episode, John Gagliano and Sheff discuss current trends in the biotech market, focusing on investment strategies, the importance of catalyst dates, and stock evaluation. Sheff shares insights on his watchlist for upcoming biotech plays, emphasizing the importance of due diligence in making informed investment decisions. The conversation highlights the potential of small-cap stocks and the dynamics of trading around specific actionable dates. In this episode: 🔹Investors should conside...

4 months ago

1 hour 1 minute

Biotech Bulls & Breakthroughs

Unlocking Biotech: Insights from The Biotech Investor (Waseem Laroussi)

In this episode, biotech content creator The Biotech Investor (Wassim Laroussi) shares his unique journey into biotech investing, discussing his background, strategies for selecting biotech stocks, and insights on current market trends. He emphasizes the importance of understanding the business behind biotech companies, the risks involved, and the potential for significant returns. Waseem also highlights the future of biotech, including the impact of AI and upcoming breakthroughs. 📲 Fol...

4 months ago

30 minutes

Biotech Bulls & Breakthroughs

Ep. 2: The Future of Oncology: Key Takeaways from ASCO | Biotech Bulls & Breakthroughs Podcast

In this episode, John Gagliano and Sheff discuss the recent ASCO conference, its significance in the oncology space, and key takeaways from the event. They delve into the importance of biotech conferences for investors, analyze oncology companies and their drug development strategies, and explore investment strategies focusing on smaller biotech firms. The conversation also touches on the role of AI in drug development and highlights current watchlist stocks with upcoming catalysts. In this ...

5 months ago

40 minutes

Biotech Bulls & Breakthroughs

Special Ep.: FT US Pharma and Biotech Summit, Pharma Optimism in Uncertain Times | Biotech Bulls & Breakthroughs Podcast

In this episode of Biotech Bulls and Breakthroughs, John Gagliano shares insights from the Financial Times US Pharma and Biotech Summit, discussing the optimism among pharma executives despite market volatility, the rise of innovation in China, trends in mergers and acquisitions, and the evolving role of AI in biotech. He also previews key highlights from the upcoming ASCO conference, emphasizing the importance of these events for investors and the biotech community. Takeaways Pharma execut...

5 months ago

24 minutes

Biotech Bulls & Breakthroughs

Ep.1: Tariffs, GLP-1 Trends & Sheff's Catalyst To Watch

In the inaugural episode of Biotech Bulls and Breakthroughs, John Gagliano and Sheff discuss the current state of the biotech market, focusing on trends, investor insights, and the impact of tariffs and FDA regulations. They explore the volatility in the market, the implications of recent tariffs on drug manufacturing, and the ongoing developments in the GLP-1 market. The conversation highlights the resilience of biotech companies and the potential for mergers and acquisitions as firms naviga...

6 months ago

58 minutes